Does BENDAMUSTINE Cause Malignant neoplasm progression? 664 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 664 reports of Malignant neoplasm progression have been filed in association with BENDAMUSTINE (VIVIMUSTA). This represents 3.4% of all adverse event reports for BENDAMUSTINE.
664
Reports of Malignant neoplasm progression with BENDAMUSTINE
3.4%
of all BENDAMUSTINE reports
221
Deaths
153
Hospitalizations
How Dangerous Is Malignant neoplasm progression From BENDAMUSTINE?
Of the 664 reports, 221 (33.3%) resulted in death, 153 (23.0%) required hospitalization, and 32 (4.8%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BENDAMUSTINE. However, 664 reports have been filed with the FAERS database.
What Other Side Effects Does BENDAMUSTINE Cause?
Off label use (2,578)
Disease progression (2,456)
Pyrexia (1,322)
Neutropenia (1,256)
Drug ineffective (1,135)
Febrile neutropenia (1,005)
Pneumonia (975)
Thrombocytopenia (967)
Covid-19 (892)
Anaemia (817)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which BENDAMUSTINE Alternatives Have Lower Malignant neoplasm progression Risk?
BENDAMUSTINE vs BENDROFLUMETHIAZIDE
BENDAMUSTINE vs BENIDIPINE
BENDAMUSTINE vs BENLYSTA
BENDAMUSTINE vs BENRALIZUMAB
BENDAMUSTINE vs BENSERAZIDE